name,mname,sname,biologic,route,approval_date,end_datecDMARDs,cDMARDs,cdmards,0,injection,12/31/1988,11/6/2017abatacept IV + methotrexate,ABT IV + MTX,abtivmtx,1,infusion/injection,12/23/2005,11/6/2017adalimumab + methotrexate,ADA + MTX,adamtx,1,injection,12/31/2002,11/6/2017adalimumab,ADA,ada,1,injection,12/31/2002,11/6/2017etanercept + methotrexate,ETN + MTX,etnmtx,1,injection,11/2/1998,11/6/2017etanercept,ETN,etn,1,injection,11/2/1998,11/6/2017golimumab + methotrexate,GOL + MTX,golmtx,1,injection,4/24/2009,11/6/2017infliximab + methotrexate,IFX + MTX,ifxmtx,1,infusion/injection,11/10/1999,11/6/2017placebo,Placebo,placebo,0,none,,11/6/2017tocilizumab + methotrexate,TCZ + MTX,tczmtx,1,injection,10/21/2013,11/6/2017tocilizumab,TCZ,tcz,1,injection,10/21/2013,11/6/2017certolizumab pegol + methotrexate,CZP + MTX,czpmtx,1,injection,4/22/2008,11/6/2017abatacept SC + methotrexate,ABT SC + MTX,abtscmtx,1,injection,8/2/2011,11/6/2017non-biologic,NBT,nbt,0,injection,,11/6/2017rituximab + methotrexate,RTX + MTX,rtxmtx,1,infusion/injection,2/28/2006,11/6/2017tofacitinib citrate + methotrexate,TOF + MTX,tofmtx,1,oral/injection,11/6/2012,11/6/2017rituximab,RTX,rtx,1,injection,2/28/2006,11/6/2017tofacitinib citrate,TOF,tof,1,oral,11/6/2012,11/6/2017certolizumab pegol,CZP,czp,1,injection,4/22/2008,11/6/2017golimumab,GOL,gol,1,injection,4/24/2009,11/6/2017